Lakeside Holding Limited
NASDAQ Capital MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Lakeside Holding Limited Lakeside Holding Limited (NASDAQ: LSH) is a U.S.-based integrated cross-border supply chain solution provider with a strategic focus on the Asian market, including China and South Korea; it offers customized cross-border ocean freight and airfreight solutions, including freight consolidation and forwarding, customs clearance, container unloading, warehousing and distribution, unpacking and packing, ground transportation, and pick-and-pack fulfillment services, primarily through its American Bear Logistics brand with operations in Chicago, Dallas, Los Angeles, and New York; following its acquisition of Hupan Pharmaceutical (Hubei) Co. in late 2024 for $0.6 million, it has expanded into pharmaceutical logistics and distribution in China, securing partnerships such as distribution agreements with Kelun Pharmaceutical in January 2025 and a $1.5 million sales agreement with Sinopharm Holding Hubei New Special Medicine Co., Ltd. in November 2024; the company, founded in 2018 and headquartered in Itasca, Illinois, serves Asia- and U.S.-based logistics firms supporting e-commerce platforms, social commerce, and manufacturers transporting consumer and industrial goods into the U.S.
Lakeside (NASDAQ:LSH) and Jungheinrich (OTCMKTS:JGHAF) Critical Analysis
Lakeside (NASDAQ:LSH) Trading Down 2.9% – Time to Sell?
Critical Survey: Lakeside (NASDAQ:LSH) versus Shengfeng Development (NASDAQ:SFWL)
Financial Review: Callan JMB (NASDAQ:CJMB) versus Lakeside (NASDAQ:LSH)
Lakeside (NASDAQ:LSH) and Universal Logistics (NASDAQ:ULH) Head to Head Analysis
Lakeside (NASDAQ:LSH) Trading Down 1.8% – Here’s What Happened
Lakeside Announces Fiscal 2025 Third Quarter and Nine-Month Results
LAKESIDE HOLDING ANNOUNCES A CONVERTIBLE DEBT FINANCING OF UP TO $4.5 MILLION
Lakeside Announces Fiscal 2025 Second Quarter and Six-Month Results
Lakeside Secures New Distribution Agreements with Kelun Pharmaceutical
Lakeside Partners with Huiyu Pharmaceutical to Revolutionize Oncology Drug Distribution
Lakeside Signs $1.5 Million Sales Agreement with Sinopharm Group Subsidiary
Lakeside Holding to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference
Lakeside Strengthens Market Position in China's Pharmaceutical Logistics with Key Sinopharm(Hubei) Contracts
LAKESIDE HOLDING PROVIDES FIRST QUARTER OF FISCAL YEAR 2025 RESULTS
Lakeside Holding Enters Medical Logistics Sector with Acquisition of Hupan Pharmaceutical (Hubei) Co., Ltd.
Lakeside Holding Reports Impressive 42% Revenue Growth for Fiscal Year 2024
LAKESIDE HOLDING EXPANDS DALLAS-FORT WORTH OPERATIONS WITH NEW OFFICE AND WAREHOUSE LEASE
LAKESIDE HOLDING LAUNCHES NEW PICK & PACK FULFILLMENT SERVICE ACROSS KEY U.S. HUBS FOR LONGSTANDING CHINA LOGISTICS PARTNER
Update: Lakeside Holding Partners With Leading Global Social Media and E-Commerce Platform to Streamline Cross-Border Fulfillment